Why the study?
Durable success using TEER with the MitraClip system in patients with advanced heart failure and unsuitable anatomy remains a clinical challenge.
Is Impella-assisted TEER feasible in patients with SMR and HFrEF on inotropic support?
Is Impella-assisted TEER feasible in patients with SMR and HFrEF on inotropic support?
Impella-assisted TEER may be a feasible strategy for patients with SMR and HFrEF with unstable hemodynamics.
May support feasibility of Impella-assisted TEER in unstable SMR/HFrEF; hypothesis-generating and requires prospective validation.
Background: Secondary mitral regurgitation (SMR) is a major comorbidity in patients with heart failure with reduced ejection fraction (HFrEF). Transcatheter edge-to-edge repair (TEER) using the MitraClip™ system is a promising tool for selected patients with SMR and HFrEF. Durable success using this system in patients who have advanced heart failure and unsuitable anatomy remains a clinical challenge. Case summary: Three patients aged 67-72 years with HFrEF on inotropic support successfully underwent Impella®-assisted TEER at our centre. Following the procedure, two patients were able to be weaned off inotropic support and were discharged, while one patient expired during the index hospitalization. Discussion: Impella®-assisted TEER may be a feasible strategy for patients with SMR and HFrEF with unstable haemodynamics particularly when cardiac replacement therapy is not applicable.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: